The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II.


Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 27 11 2019
accepted: 02 12 2019
pubmed: 23 1 2020
medline: 26 3 2021
entrez: 23 1 2020
Statut: ppublish

Résumé

With three out of four new bladder cancer (BCa) cases occurring in men, an apparent gender disparity exists. We aimed to investigate the role of hormonal and reproductive factors in BCa risk using two large female US prospective cohorts. Our study population comprised 118 256 and 115 383 female registered nurses who were recruited in the Nurses' Health Study (NHS) and NHS II, respectively. Reproductive and hormonal factors and other relevant data were recorded in biennial self-administered questionnaires. Cox-regression analyses were performed to estimate age- and multivariable-adjusted incidence risk ratios (IRRs) and 95% confidence intervals (CIs). Inverse-variance-weighted meta-analysis was used to pool estimates across cohorts. During up to 36 years of follow-up, 629 incident BCa cases were confirmed. In the NHS, 22 566 women (21.3%) were postmenopausal at baseline, compared with 2723 women (2.4%) in the NHS II. Among women in the NHS, younger age at menopause (≤45 years) was associated with an increased risk of BCa (IRR: 1.41, 95% CI: 1.11-1.81, Ptrend = 0.01) compared with those with menopause onset at age 50+ years, particularly among ever-smokers (IRR for age at menopause ≤45 years: 1.53, 95% CI: 1.15-2.04; PIntx = 0.16). Age at menarche and first birth, parity, oral-contraceptive use and postmenopausal hormone use were not associated with BCa risk. Overall, we found little support for an association between female reproductive factors and BCa risk in these prospective cohort studies. Earlier age at menopause was associated with a higher risk of BCa, particularly among smokers, indicating the potential for residual confounding.

Sections du résumé

BACKGROUND
With three out of four new bladder cancer (BCa) cases occurring in men, an apparent gender disparity exists. We aimed to investigate the role of hormonal and reproductive factors in BCa risk using two large female US prospective cohorts.
METHODS
Our study population comprised 118 256 and 115 383 female registered nurses who were recruited in the Nurses' Health Study (NHS) and NHS II, respectively. Reproductive and hormonal factors and other relevant data were recorded in biennial self-administered questionnaires. Cox-regression analyses were performed to estimate age- and multivariable-adjusted incidence risk ratios (IRRs) and 95% confidence intervals (CIs). Inverse-variance-weighted meta-analysis was used to pool estimates across cohorts.
RESULTS
During up to 36 years of follow-up, 629 incident BCa cases were confirmed. In the NHS, 22 566 women (21.3%) were postmenopausal at baseline, compared with 2723 women (2.4%) in the NHS II. Among women in the NHS, younger age at menopause (≤45 years) was associated with an increased risk of BCa (IRR: 1.41, 95% CI: 1.11-1.81, Ptrend = 0.01) compared with those with menopause onset at age 50+ years, particularly among ever-smokers (IRR for age at menopause ≤45 years: 1.53, 95% CI: 1.15-2.04; PIntx = 0.16). Age at menarche and first birth, parity, oral-contraceptive use and postmenopausal hormone use were not associated with BCa risk.
CONCLUSIONS
Overall, we found little support for an association between female reproductive factors and BCa risk in these prospective cohort studies. Earlier age at menopause was associated with a higher risk of BCa, particularly among smokers, indicating the potential for residual confounding.

Identifiants

pubmed: 31965144
pii: 5713010
doi: 10.1093/ije/dyz264
pmc: PMC7266530
doi:

Substances chimiques

Hormones 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-607

Subventions

Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : ACL HHS
ID : R01OH009803
Pays : United States
Organisme : NIOSH CDC HHS
ID : R01 OH009803
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA207736
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL034594
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States

Informations de copyright

© The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Références

JAMA Oncol. 2015 Dec;1(9):1282-90
pubmed: 26448641
BMJ. 2014 Oct 31;349:g6356
pubmed: 25361731
Int J Cancer. 2006 Nov 15;119(10):2398-401
pubmed: 16894568
BJU Int. 2013 Jul;112(1):68-73
pubmed: 23320798
BJU Int. 2010 Feb;105(3):300-8
pubmed: 19912200
Nat Rev Urol. 2015 Dec;12(12):653
pubmed: 26481574
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
World J Urol. 2011 Aug;29(4):457-63
pubmed: 21656173
Am J Epidemiol. 1984 May;119(5):837-9
pubmed: 6720679
Int J Cancer. 2007 Mar 1;120(5):1093-8
pubmed: 17131327
Am J Epidemiol. 2006 Feb 1;163(3):236-44
pubmed: 16319290
Eur Urol. 2013 Apr;63(4):733-8
pubmed: 23332884
PLoS One. 2017 Mar 31;12(3):e0174746
pubmed: 28362839
Int J Cancer. 2013 Jul 15;133(2):462-72
pubmed: 23319449
Cancer Causes Control. 2009 Dec;20(10):1907-13
pubmed: 19568699
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Am J Epidemiol. 1987 Aug;126(2):319-25
pubmed: 3605058
Eur J Surg Oncol. 2015 Mar;41(3):368-77
pubmed: 24674298
Eur Urol. 2016 Feb;69(2):300-10
pubmed: 26346676
J Urol. 2014 Oct;192(4):1072-7
pubmed: 24835058
Am J Epidemiol. 1983 Jun;117(6):651-8
pubmed: 6859020
Eur Urol. 2018 Dec;74(6):784-795
pubmed: 30268659
Nat Rev Urol. 2013 Jun;10(6):317-26
pubmed: 23588401
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31(4):287-304
pubmed: 24171436
Eur Urol. 2016 Oct;70(4):611-620
pubmed: 26988609
Am J Public Health. 2016 Sep;106(9):1573-81
pubmed: 27459450

Auteurs

Mohammad Abufaraj (M)

Department of Urology, Medical University of Vienna, Vienna, Austria.
Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.

Shahrokh Shariat (S)

Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA.
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Marco Moschini (M)

Department of Urology, Medical University of Vienna, Vienna, Austria.

Florian Rohrer (F)

Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.

Kyriaki Papantoniou (K)

Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.

Elizabeth Devore (E)

Channing Division of Network Medicine, Harvard Medical School, Boston, MA, USA.

Monica McGrath (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Xuehong Zhang (X)

Channing Division of Network Medicine, Harvard Medical School, Boston, MA, USA.

Sarah Markt (S)

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Eva Schernhammer (E)

Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.
Channing Division of Network Medicine, Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH